"As a Family Medicine provider, Montgomery Medical offers comprehensive health care to patients of all ages, from infants to the elderly. We specialize it treating the whole family. Lab draws, flu and strep screens along with Ultrasound and EMG testing is available on site."

During the past decade, Montgomery Medical, Inc. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montgomery Medical, Inc." #1 sponsor was "Allergan" with 3 trials, followed by "Forest Laboratories" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Kindeva Drug Delivery" with 1 trials sponsored and "Kowa Research Institute, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montgomery Medical, Inc." #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 3 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Montgomery Medical, Inc." are "Gastroparesis" (3 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus" (2 trials), "Irritable Bowel Syndrome With Constipation" (2 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Montgomery Medical, Inc." in a lesser frequency.

Most popular intervention types in "Montgomery Medical, Inc." are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Relamorelin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Budesonide/Formoterol fumarate dihydrate" (1 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montgomery Medical, Inc." are 10 trials for "All" genders.

Currently, there are NaN active trials in "Montgomery Medical, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Montgomery Medical, Inc., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Montgomery Medical, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".